Can-Fite BioPharma Ltd. Other Noncash Income (Expense)
Can-Fite BioPharma Ltd. (CANF) reported Other Noncash Income (Expense) of -$36.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-03-26
| Period end | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$36.00K 20-F · filed 2026-03-26 | ||
| 2024-12-31 | -$90.00K 20-F · filed 2026-03-26 | ||
| 2024-06-30 | -$144.00K 6-K · filed 2024-08-29 | ||
| 2023-12-31 | $222.00K 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $146.00K 6-K · filed 2024-08-29 | ||
| 2022-12-31 | -$113.00K 20-F · filed 2025-04-14 | ||
| 2021-12-31 | $46.00K 20-F · filed 2024-03-28 | $34.00K 20-F · filed 2022-03-24 | |
| 2020-12-31 | -$23.00K 20-F · filed 2023-03-30 | ||
| 2019-12-31 | $2.00K 20-F · filed 2022-03-24 |